Karrie International Holdings Limited (01050.HK) released a voluntary announcement disclosing multiple progress milestones in its artificial intelligence (AI) server business. The Group has secured server chassis orders from a leading AI enterprise and entered the mass production phase, while also obtaining the product design for the client’s next-generation AI architecture. In addition, the Group has commenced mass production of ASIC server chassis for a leading U.S. tech enterprise and expects robust capacity demand in 2026.
JNBY Design Limited (03306.HK) announced that the Company has entered into a placing agreement with the placing agent, proposing to place a maximum of 14.535 million new shares at a price of HK$18.78 per share (representing a discount of approximately 9.01% to the previous day's closing price), with an expected net proceeds of approximately HK$270 million. The placing shares will be issued pursuant to the general mandate, without the need for additional shareholder approval.
On January 22, PHARMARON announced the completion of its H-share placement. The company placed 58,440,800 new H-shares to no fewer than six independent placees at a price of HK$22.82 per share, raising net proceeds of approximately HK$1.319 billion. The funds will be used for facility construction, debt repayment, and working capital supplementation. Following the placement, the proportion of H-shares in the company’s total issued share capital has increased to 19.28%.
On January 22, 51WORLD announced that the stabilization period for its global offering has expired on the same day. No stabilization actions were taken during the period, and the over-allotment option has lapsed due to no over-allocation. The company’s public float continues to comply with the requirements of the listing rules.
The Securities and Futures Commission of Hong Kong (SFC) issued an announcement stating that the shareholding of Affluent Foundation Holdings Limited (01757.HK) is highly concentrated in a small number of shareholders. As of January 12, 2026, the company's largest shareholder and another 25 shareholders held a combined shareholding of 90.63%, with only 9.37% of the shares held by other investors. The SFC warned that highly concentrated shareholding may lead to substantial fluctuations in the share price, and investors are advised to exercise extreme caution when trading the shares.
On January 22, PRUDENTIAL announced that its indirectly wholly-owned subsidiary PCHL has agreed to acquire a 19% equity stake in SHS, the holding company of its Malaysian life insurance business, from Detik Ria for approximately US$375 million (1.52 billion Malaysian ringgit). Upon completion of the transaction, Prudential’s ownership in SHS will increase from 51% to 70%, further consolidating its presence in the Southeast Asian life insurance market.
Shanghai INT Medical Instruments Co., Ltd. (01501.HK) announced that the previously disclosed share placement was completed on January 22, 2026. The Company successfully placed a total of 35.2 million new H shares at a price of HK$26.00 per share to no fewer than six independent placees. The net proceeds of approximately HK$884 million will be used for business expansion, loan repayment and general working capital.
Venus Medtech (Hangzhou) Inc. (02500.HK) announced that its associated company Cardiovalve Ltd. has filed a patent infringement lawsuit against Edwards Lifesciences with the United States District Court for the District of Delaware, alleging that Edwards' core product, the PASCAL Precision System, has infringed the U.S. patent held by Cardiovalve Ltd.. The litigation is still at the preliminary stage.
Hongxing Coldchain's stock price performance has been sluggish since listing, falling for five consecutive trading days since January 15, 2026, and has fallen below the issue price of HK$12.26. According to a CIC report, the company is the largest frozen food warehousing service provider in central China, with a 13.6% market share in 2024. The prospectus shows that the company's 2024 revenue was RMB 234 million, but it experienced a "increasing revenue without increasing profit" situation in the first half of 2025. During the reporting period, its northern base's capacity utilization and renewal rates declined, and it faced pressure from new competitors entering the market.
Tian Ge Interactive Holdings Limited (01980.HK) announced that it has received a letter of firm intention from Sina Hong Kong Limited, which proposes to make a voluntary conditional cash partial tender offer to acquire 32.5 million shares of the Company (excluding the shares already held by Sina Hong Kong and its concert parties). The Company's shares will resume trading at 9:00 a.m. on January 22, 2026.
Domaine Power Holdings Limited (00442.HK) announced that its rights issue has been oversubscribed by approximately 15.49%, raising net proceeds of around HK$58 million. The rights shares are expected to commence trading on the Stock Exchange of Hong Kong Limited (SEHK) on January 23, 2026.
JINGCHENG MAC issued a 2025 annual performance forecast announcement, expecting the full-year net profit attributable to shareholders of the parent company to be a loss of RMB 46 million to RMB 55.2 million, turning from a profit of RMB 7.477 million in the same period last year to a loss. The net profit after deducting non-recurring gains and losses is projected to be a loss of RMB 74.6 million to RMB 89.5 million, with the loss scale significantly expanding compared with the same period last year.
SH ELECTRIC issued a 2025 performance forecast announcement on January 21, expecting the full-year net profit attributable to shareholders of the parent company to be RMB 1.1 billion to RMB 1.32 billion, a year-on-year increase of 47% to 76%. The non-IFRS net profit is projected to be RMB 200 million to RMB 240 million, turning from a loss of RMB 620 million in the same period last year to a profit.
Kanzhun Limited, the parent company of BOSS ZHIPIN-W, issued a voluntary announcement on January 21, disclosing that its trustee repurchased 315,230 Class A common shares in the open market on January 20 in accordance with the share plan. The repurchase was funded by the company’s internal resources, with an average cost of USD 9.49 per share, accounting for approximately 0.03% of the company’s issued and outstanding shares.
Xiao Noodles was listed on the Hong Kong Stock Exchange on December 5, 2025, with an IPO price of HK$7.04 per share. The stock price has remained sluggish since listing, with the closing price as of January 20, 2026 down 37.36% from the issue price. The prospectus shows that the company's 2024 revenue was RMB 1.154 billion, and it achieved a turnaround to profitability with net profit reaching RMB 60.7 million.
SIMCERE PHARMA(02096.HK) will spend HKD 22.21 million to repurchase 1.88 million shares on Jan 20, 2026 .
